There were 2,326 press releases posted in the last 24 hours and 441,215 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Zealand Pharma initiates second Phase 3 trial with dasiglucagon for the treatment of congenital hyperinsulinism

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image